CLDX | NASDAQ Stock Exchange

Celldex Therapeutics
+ Share

Donchian Channels /
Closing price for CLDX is still above the upper Donchian Band signalling a bearish movement

[BEARISH]: Celldex Therapeutics is currently bearish highlighting the potential for a short term trend continuation in the downward direction.

Average Directional Movement /
Recent trading indicates ADX weak trend direction likely for CLDX

[Weak Trend]: ADX for CLDX has confirmed a weak trend is present. Celldex Therapeutics has an ATR(14) of 0.028, a DX of 11.11 & an ADX(14) of 18.5

Medium Trend /
Second timeframe trend of Celldex Therapeutics remains as an Uptrend

[BULLISH]: Celldex Therapeutics is in an uptrend in the medium term timeframe. The current rally number is 17 & the highest rally count for the LTM is 33. The highest rally for the month is 15

Momentum /
Positive momentum: Price is now trading higher for Celldex Therapeutics than 5 days ago

[BULLISH CROSSOVER]: Celldex Therapeutics currently has positive momentum of 0.03. This means the current price is greater than the price 5 days ago and therefore gaining momentum. Currently, the return on momentum is 7.1%. The largest upward momentum rally for the last 3 months is 1 days producing a return of 7.1%.

White Opening Marubozu /
CLDX Basic Candle: White Opening Marubozu

[BULLISH]: Celldex Therapeutics has formed a White Opening Marubozu candlestick. This means, CLDX has received strong buying confidence and upward price movement over the trading day with only a small upper shadow present. Given the limited timeframe in which signal has formed, further confirmation is required through volume and additional technical indicators.

Exponential Moving Average /
Exponential Moving Average(5) signal is confirmed for Celldex Therapeutics indicating upward price movement is likely

[BULLISH]: Celldex Therapeutics currently has a confirmed uptrend. Recent trading has caused the EMA 5 day average to exceed the closing price confirming the short term trend following indicator. Currently, the return on EMA5 is 7.1%.

Open Tod Vs Close Tod /
Open/close reversal: Buyers have lost commitment during the trading day for CLDX

CLDX: Open today versus close yesterday Current Signal ->(1) 24 Sep: BULLISH WEAK (2) 21 Sep: BEARISH (3) 20 Sep: NEUTRAL

MACD Volume /
Celldex Therapeutics: Volume MACD oscillator (41368)

[BULLISH]: Celldex Therapeutics currently has positive Volume MACD of 41368. This means the signal line is greater than the Volume MACD line signalling a bullish movement.

Daily Volume Index /
Traders are currently distributing Celldex Therapeutics

[BEARISH]: Celldex Therapeutics (NASDAQ:CLDX) current distribution has given weakness to the share price and the continuation of bearish trading conditions. Currently, the DVI is -11529.

Aroon Oscillator /
Celldex Therapeutics has signalled an Aroon trend present [Uptrend]

[BULLISH]: Celldex Therapeutics has a current ARO(25) of 24. This has change 0 points from yesterday.

Triangular Moving Average /
The TMA trend following signal is still current for Celldex Therapeutics [Bullish]

CLDX: TMA Recent Trading -> (1) 24 Sep: 0.4200 (2) 21 Sep: 0.4180 (3) 20 Sep: 0.4180

On Balance Volume /
Distribution OBV signal for CLDX is confirmed

CLDX: OBV Current Signal ->(1) 24 Sep: BEARISH (2) 21 Sep: BEARISH (3) 20 Sep: BEARISH

Ease of Movement /
Celldex Therapeutics was difficult to move upward due to high volume in recent trading [Bullish]

CLDX: EOM Current Signal -> (1) 24 Sep: BULLISH HARD (2) 21 Sep: BULLISH HARD (3) 20 Sep: BULLISH HARD

Percentage Volume /
Celldex Therapeutics: Percentage Volume Oscillator @-2.97 [Bearish]

[BEARISH]: Celldex Therapeutics currently has negative PVO -2.97%. The recent volume is losing momentum through a fall on the short term exponential moving average.

Elder Ray Index /
Bull power has increased for Celldex Therapeutics signalling bullish conditions are likely

[BULLISH]: Celldex Therapeutics Elder Ray Index is signalling a Bullish movementERI is 0.027 indicating bull power. Prices are being driven above the consensus of value for CLDX during the last trading session [Buying Pressure]

Demarks Pivot Points /
Celldex Therapeutics has moved above the R1 DeMark pivot point ($0.45) [Bullish]

Celldex Therapeutics current pivot point (DeMark) is: (R1) $0.47. The current pivot point (DeMark) is: (S1) $0.44.

Close Tod Vs Range Tod /
This is the first day of buyer commitment for Celldex Therapeutics adding strength to an uptrend in the first timeframe

[BULLISH]: Celldex Therapeutics buyers are in control at the market close. This is the first day of buyer commitment for Celldex Therapeutics adding strength to an uptrend in the first timeframe & highlights the commitment of buyers to carry positions overnight. Over the last 12 months there has been 2 trading days with the closing price in the upper part of the range giving a confirmation ratio of 0.8%. Over the last month there has been 2 trading days with the closing price in the upper range giving a confirmation ratio of 13.3%. Currently this quarter, closing price has spent 2 days in the upper price range compared to 3 days in the lower range giving a ratio of 0.7x.

Pivot Points /
Celldex Therapeutics has moved above the R1 pivot point ($0.464) [Bullish]

Celldex Therapeutics has broken the first resistance point ($0.464) [Bullish]. Look for a long limit order entry near this point. Exit price for CLDX should be set @$0.477 & Stoploss for Celldex Therapeutics should be set between $0.417 & $0.404

Detrended Price Oscillator /
Daily trading has confirmed the DPO(20) is bearish for Celldex Therapeutics

[BEARISH]: Celldex Therapeutics currently has a confirmed downtrend. Price is currently below the displaced moving average for CLDX. Currently, the return on DPO20 is 7.1%.

Moving Average Envelope /
Celldex Therapeutics is still oversold with the Lower Envelope Band @$0.418

[BULLISH]: Celldex Therapeutics current trading has maintained the Envelope Bands to oversold status and signalled the continuation of the bullish trading conditions. Currently, the Lower Band is 0.418.

Simple Moving Average /
Celldex Therapeutics: Simple Moving Average(5) (0.426)

[BULLISH]: Celldex Therapeutics currently has a confirmed uptrend. Recent trading has caused the SMA 5 day average to exceed the closing price confirming the short term trend following indicator. Currently, the return on SMA5 is 7.1%.

Bull Separating Lines /
Celldex Therapeutics: Bull Separating Lines

CLDX: Continuation Recent Trading -> (1) 24 Sep: Bull Separating Lines (2) 21 Sep: (3) 20 Sep:

Bill Williams Market Facilitation /
[Fake Day]: MFI indicator is up, volume is down CLDX

CLDX: BWMF Current Signal -> (1) 24 Sep: Fake Day (2) 21 Sep: Squat Day (3) 20 Sep: Fake Day

Ulcer Index /
Drawdown for Celldex Therapeutics is currently high signalling high stress

[BULLISH]: Celldex Therapeutics UIX index implies that the downside risk of the current trading price is high. Currently, the UIX is 13.755.

Elders Force Index /
Price & volume confirms continued selling pressure for Celldex Therapeutics is likely

[BEARISH]: Celldex Therapeutics current price has highlighted recent selling pressure. Currently, the Elders Force Index is -6839.

Coles Reaction Day /
CLDX: Short term trend has confirmed a rally day

Celldex Therapeutics: Coles Rally Day has been confirmed A higher high has been achieved for last trading day for CLDX

Woodie Pivot Point /
Celldex Therapeutics: Woodie Pivot ($0.448)

Celldex Therapeutics current pivot point (Woodie) is: $0.448. The current resistance levels are: (R1) $0.466: (R2) $0.478The current support levels are: (S1) $0.436: (S2) $0.418

Rate of Change /
14-day rate of change is decreasing for Celldex Therapeutics

[BEARISH]: Celldex Therapeutics currently has negative rate of change of -4.255%. This means the current price is less than the price 14 days ago and therefore losing momentum & is a leading indicator of price movement in the downward direction

Stochastic Oscillator /
Celldex Therapeutics is no longer oversold [Neutral]

CLDX: Stochastic Oscillator Trading -> (1) 24 Sep: 44.4 (2) 21 Sep: 11.1 (3) 20 Sep: 22.2

See More   See more results
back to top